Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:APGN

Apexigen (APGN) Stock Price, News & Analysis

Apexigen logo

About Apexigen Stock (NASDAQ:APGN)

Key Stats

Today's Range
$0.39
$0.39
50-Day Range
$0.36
$0.44
52-Week Range
$0.33
$8.28
Volume
N/A
Average Volume
967,731 shs
Market Capitalization
$9.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Apexigen, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. Apexigen, Inc. was founded in 2010 and is headquartered in San Carlos, California.

Receive APGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apexigen and its competitors with MarketBeat's FREE daily newsletter.

APGN Stock News Headlines

A Simple Trading Strategy You Should Know
It’s no secret, I love big, juicy options trades. But when you’re chasing the BIG fish, you gotta have a way to target some steady, consistent returns in there as well. Check out the $100 Challenge This Chris Pulver, he’s isolated a way for everyday folks to target $100-$150 a day in the stock market, starting with just $1,000 or so. And while we cannot promise future returns or against losses, It’s the perfect supplement to more aggressive options strategies… And right now, everyone needs more cash in this economy.
APG SGA S.A.
See More Headlines

APGN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Apexigen investors own include Sunworks (SUNW), Applied DNA Sciences (APDN), Ginkgo Bioworks (DNA), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Mullen Automotive (MULN) and Ambrx Biopharma (AMAM).

Company Calendar

Today
12/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APGN
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Net Income
$-32,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.09) per share

Miscellaneous

Free Float
20,088,000
Market Cap
$9.57 million
Optionable
Not Optionable
Beta
3.60
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:APGN) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners